| Circulating microRNAs as candidate markers to distinguish heart failure in breathless patients KL Ellis, VA Cameron, RW Troughton, CM Frampton, LJ Ellmers, ... European journal of heart failure 15 (10), 1138-1147, 2013 | 229 | 2013 |
| Value of measuring lipoprotein (a) during cascade testing for familial hypercholesterolemia KL Ellis, L Pérez de Isla, R Alonso, F Fuentes, GF Watts, P Mata Journal of the American College of Cardiology 73 (9), 1029-1039, 2019 | 125 | 2019 |
| The renaissance of lipoprotein (a): brave new world for preventive cardiology? KL Ellis, MB Boffa, A Sahebkar, ML Koschinsky, GF Watts Progress in Lipid Research 68, 57-82, 2017 | 81 | 2017 |
| Association between the chromosome 9p21 locus and angiographic coronary artery disease burden: a collaborative meta-analysis K Chan, RS Patel, P Newcombe, CP Nelson, A Qasim, SE Epstein, ... Journal of the American College of Cardiology 61 (9), 957-970, 2013 | 81 | 2013 |
| Association of genetic variation in the natriuretic peptide system with cardiovascular outcomes KL Ellis, C Newton-Cheh, TJ Wang, CM Frampton, RN Doughty, ... Journal of molecular and cellular cardiology 50 (4), 695-701, 2011 | 73 | 2011 |
| A Common Variant at Chromosome 9P21. 3 Is Associated With Age of Onset of Coronary Disease but Not Subsequent MortalityClinical Perspective KL Ellis, AP Pilbrow, CM Frampton, RN Doughty, GA Whalley, CJ Ellis, ... Circulation: Cardiovascular Genetics 3 (3), 286-293, 2010 | 73 | 2010 |
| Familial combined hyperlipidemia and hyperlipoprotein (a) as phenotypic mimics of familial hypercholesterolemia: frequencies, associations and predictions KL Ellis, J Pang, DC Chan, AJ Hooper, DA Bell, JR Burnett, GF Watts Journal of clinical lipidology 10 (6), 1329-1337. e3, 2016 | 58 | 2016 |
| Genomic risk variants at 1p13. 3, 1q41, and 3q22. 3 are associated with subsequent cardiovascular outcomes in healthy controls and in established coronary artery disease KL Ellis, CM Frampton, AP Pilbrow, RW Troughton, RN Doughty, ... Circulation: Cardiovascular Genetics 4 (6), 636-646, 2011 | 46 | 2011 |
| Elevated lipoprotein (a) and familial hypercholesterolemia in the coronary care unit: between Scylla and Charybdis KL Ellis, J Pang, D Chieng, DA Bell, JR Burnett, CJ Schultz, GS Hillis, ... Clinical cardiology 41 (3), 378-384, 2018 | 43 | 2018 |
| Genetic variation in the renin–angiotensin–aldosterone system is associated with cardiovascular risk factors and early mortality in established coronary heart disease KL Ellis, BR Palmer, CM Frampton, RW Troughton, RN Doughty, ... Journal of human hypertension 27 (4), 237-244, 2013 | 42 | 2013 |
| Progress in the care of common inherited atherogenic disorders of apolipoprotein B metabolism KL Ellis, AJ Hooper, JR Burnett, GF Watts Nature Reviews Endocrinology 12 (8), 467-484, 2016 | 36 | 2016 |
| Elevated lipoprotein (a) and low-density lipoprotein cholesterol as predictors of the severity and complexity of angiographic lesions in patients with premature coronary artery … D Chieng, J Pang, KL Ellis, GS Hillis, GF Watts, CJ Schultz Journal of Clinical Lipidology 12 (4), 1019-1026, 2018 | 35 | 2018 |
| Lipoprotein (a) and apolipoprotein (a) isoform size: associations with angiographic extent and severity of coronary artery disease, and carotid artery plaque EMM Ooi, KL Ellis, PHR Barrett, GF Watts, J Hung, JP Beilby, ... Atherosclerosis 275, 232-238, 2018 | 34 | 2018 |
| Angiotensin-converting enzyme 2 A1075G polymorphism is associated with survival in an acute coronary syndromes cohort BR Palmer, MD Jarvis, AP Pilbrow, KL Ellis, CM Frampton, L Skelton, ... American heart journal 156 (4), 752-758, 2008 | 33 | 2008 |
| New data on familial hypercholesterolaemia and acute coronary syndromes: The promise of PCSK9 monoclonal antibodies in the light of recent clinical trials KL Ellis, J Pang, CJ Schultz, GF Watts European Journal of Preventive Cardiology 24 (11), 1200-1205, 2017 | 23 | 2017 |
| Genetic polymorphism rs6922269 in the MTHFD1L gene is associated with survival and baseline active vitamin B12 levels in post-acute coronary syndromes patients BR Palmer, S Slow, KL Ellis, AP Pilbrow, L Skelton, CM Frampton, ... PloS one 9 (3), e89029, 2014 | 20 | 2014 |
| Is lipoprotein (a) ready for prime-time use in the clinic? KL Ellis, GF Watts Cardiology clinics 36 (2), 287-298, 2018 | 17 | 2018 |
| Coronary artery disease and the risk-associated LPA variants, rs3798220 and rs10455872, in patients with suspected familial hypercholesterolaemia MM Page, KL Ellis, J Pang, DC Chan, AJ Hooper, DA Bell, JR Burnett, ... Clinica Chimica Acta 510, 211-215, 2020 | 15 | 2020 |
| Genetic modifiers of response to glucose–insulin–potassium (GIK) infusion in acute coronary syndromes and associations with clinical outcomes in the IMMEDIATE trial KL Ellis, Y Zhou, JR Beshansky, E Ainehsazan, HP Selker, LA Cupples, ... The pharmacogenomics journal 15 (6), 488-495, 2015 | 14 | 2015 |
| Cascade testing for elevated lipoprotein (a) in relatives of probands with familial hypercholesterolaemia and elevated lipoprotein (a) A Chakraborty, J Pang, DC Chan, KL Ellis, AJ Hooper, DA Bell, JR Burnett, ... Atherosclerosis 349, 219-226, 2022 | 13 | 2022 |
